Pulmonary embolism possibly associated with olanzapine treatment

Abstract
Footnotes Contribution The report was drafted and edited by both authors. IMW was responsible for the clinical care of the patient and is the guarantor. Funding None. Competing interests IMW has received reimbursement for attending conferences from Lundbeck, Pfizer, and AstraZeneca and has been paid consultant fees by AstraZeneca